<?xml version="1.0" encoding="ISO-8859-1"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.bio-medicine.org/~d/styles/itemcontent.css"?><rss xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">
<channel>
<title>Latest Medical Technology from Bio-Medicine.Org</title>
<link>http://www.bio-medicine.org/medicine-technology-1/</link>
<description>Latest Medical Technology lists</description>
<language>en-us</language>
<copyright>Copyright 2007. Bio-Medicine All Rights Reserved.</copyright>
<atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://feeds.bio-medicine.org/latest-medical-technology" /><feedburner:info uri="latest-medical-technology" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><feedburner:emailServiceId>latest-medical-technology</feedburner:emailServiceId><feedburner:feedburnerHostname>http://feedburner.google.com</feedburner:feedburnerHostname><item>
<title><![CDATA[Dubai Economic Department Recognizes Eastern Biotech's Achievement at DubaiSME100]]></title>
<link>http://feeds.bio-medicine.org/~r/latest-medical-technology/~3/pFwIXhi2nqg/</link>
<pubDate>Sun, 12 Feb 2012 07:10:50 MST</pubDate>
<description>DUBAI, UAE, February 12, 2012 /-   Eastern Biotech &amp;amp; Life Sciences, a leading healthcare biotechnology and diagnostic company, providing preventive genetic testing services in Middle East,&amp;#160;has been ranked #19 an honor list of the top Dubai SME 100. The ranking was announced by HH Sheikh Ahmed bin Saeed Al Maktoum at a special ceremony held on the 12 th  February 2012 at Dub...&lt;img src="http://feeds.feedburner.com/~r/latest-medical-technology/~4/pFwIXhi2nqg" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.bio-medicine.org/medicine-technology-1/Dubai-Economic-Department-Recognizes-Eastern-Biotechs-Achievement-at-DubaiSME100-23989-1/</feedburner:origLink></item>
<item>
<title><![CDATA[Pharmaceutical Industry Leveraging New Tools to Overcome Challenges in Market Research]]></title>
<link>http://feeds.bio-medicine.org/~r/latest-medical-technology/~3/wzoJp-HERPQ/</link>
<pubDate>Fri, 10 Feb 2012 11:23:42 MST</pubDate>
<description>CHAPEL HILL, N.C., Feb. 10, 2012 /-&amp;#160;As pharmaceutical and medical device companies evolve, market research in these companies must develop innovative capabilities while refining current ones to support intelligent planning and decision-making. Consequently,  market research  leaders are beginning to explore different types of technological advances in order to bring forth devel...&lt;img src="http://feeds.feedburner.com/~r/latest-medical-technology/~4/wzoJp-HERPQ" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.bio-medicine.org/medicine-technology-1/Pharmaceutical-Industry-Leveraging-New-Tools-to-Overcome-Challenges-in-Market-Research-23988-1/</feedburner:origLink></item>
<item>
<title><![CDATA[UBM Medica's ONCOLOGY to Feature Special Content on Role of Genetic Testing in GI Cancers]]></title>
<link>http://feeds.bio-medicine.org/~r/latest-medical-technology/~3/N07tPwbscdU/</link>
<pubDate>Fri, 10 Feb 2012 09:51:30 MST</pubDate>
<description>NORWALK, Conn., Feb. 10, 2012 /-&amp;#160;UBM Medica's  ONCOLOGY  and  CancerNetwork  today announced that the April issue will feature insights by physicians from the  clinical genetics  service at  Memorial Sloan-Kettering Cancer Center  in which they explain the role of  genetic testing  in  gastrointestinal cancers .    In the article, Kenneth Offit, MD, MPH, and colleagues bring cl...&lt;img src="http://feeds.feedburner.com/~r/latest-medical-technology/~4/N07tPwbscdU" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.bio-medicine.org/medicine-technology-1/UBM-Medicas-ONCOLOGY-to-Feature-Special-Content-on-Role-of-Genetic-Testing-in-GI-Cancers-23987-1/</feedburner:origLink></item>
<item>
<title><![CDATA[CareFusion Announces $500 Million Share Repurchase Program]]></title>
<link>http://feeds.bio-medicine.org/~r/latest-medical-technology/~3/0PJG2wKk_sE/</link>
<pubDate>Fri, 10 Feb 2012 08:52:54 MST</pubDate>
<description>SAN DIEGO, Feb. 10, 2012 /-&amp;#160; CareFusion  Corp. (NYSE:   CFN ), a leading, global medical technology company, today announced that its board of directors authorized the repurchase of up to $500 million of the company's common stock.   (Logo:&amp;#160;  http://photos.prnewswire.com/prnh/20100706/CAREFUSIONLOGO )   "This share repurchase program reflects our confidence in CareFusion's...&lt;img src="http://feeds.feedburner.com/~r/latest-medical-technology/~4/0PJG2wKk_sE" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.bio-medicine.org/medicine-technology-1/CareFusion-Announces--24500-Million-Share-Repurchase-Program-23986-1/</feedburner:origLink></item>
<item>
<title><![CDATA[Cyberonics to Present at Citi 2012 Global Health Care Conference]]></title>
<link>http://feeds.bio-medicine.org/~r/latest-medical-technology/~3/Y2tJcN_A7sE/</link>
<pubDate>Fri, 10 Feb 2012 08:52:10 MST</pubDate>
<description>HOUSTON, Feb. 10, 2012 /- Cyberonics, Inc. (NASDAQ:   CYBX ), a global leader in medical devices for the treatment and management of epilepsy, today announced it will participate in the Citi 2012 Global Health Care Conference on Monday, February 27, 2012, in New York.   Greg Browne, Senior Vice President and Chief Financial Officer, will speak at 11:00 AM Eastern Time.&amp;#160; A live...&lt;img src="http://feeds.feedburner.com/~r/latest-medical-technology/~4/Y2tJcN_A7sE" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.bio-medicine.org/medicine-technology-1/Cyberonics-to-Present-at-Citi-2012-Global-Health-Care-Conference-23985-1/</feedburner:origLink></item>
<item>
<title><![CDATA[Sixth Generation Elekta Digital Control System Boosts Radiation Therapy System Speed and Performance]]></title>
<link>http://feeds.bio-medicine.org/~r/latest-medical-technology/~3/D78-gIPBnXs/</link>
<pubDate>Fri, 10 Feb 2012 08:51:53 MST</pubDate>
<description>ATLANTA, Feb. 10, 2012 /-&amp;#160;The advanced functionality of Elekta's family of digital linear accelerators demands the highest degree of intelligent coordination. Elekta's latest control system, Integrity&amp;#8482; R1.1, meets this requirement through three tiers of safety, command of MLC interdigitation for exceptional field shaping, and support of virtually limitless options to adju...&lt;img src="http://feeds.feedburner.com/~r/latest-medical-technology/~4/D78-gIPBnXs" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.bio-medicine.org/medicine-technology-1/Sixth-Generation-Elekta-Digital-Control-System-Boosts-Radiation-Therapy-System-Speed-and-Performance-23984-1/</feedburner:origLink></item>
<item>
<title><![CDATA[Panasonic Reaches Distribution Agreement With The Hearing Shop]]></title>
<link>http://feeds.bio-medicine.org/~r/latest-medical-technology/~3/ebB3hJ6nQ-4/</link>
<pubDate>Fri, 10 Feb 2012 08:51:33 MST</pubDate>
<description>SECAUCUS, N.J., Feb. 10, 2012 /- Panasonic Healthcare Group today announced a new distribution agreement with The Hearing Shop, an online supplier for the hearing professional, which will allow licensed dispensers and audiologists to purchase Panasonic products at  www.panasonic-hearingshop.com .&amp;#160; This is the first time that Panasonic digital hearing instruments will be availab...&lt;img src="http://feeds.feedburner.com/~r/latest-medical-technology/~4/ebB3hJ6nQ-4" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.bio-medicine.org/medicine-technology-1/Panasonic-Reaches-Distribution-Agreement-With-The-Hearing-Shop-23983-1/</feedburner:origLink></item>
<item>
<title><![CDATA[VirtualScopics to Present at the 14th Annual BIO CEO &amp; Investor Conference]]></title>
<link>http://feeds.bio-medicine.org/~r/latest-medical-technology/~3/blS1bGyMVNU/</link>
<pubDate>Fri, 10 Feb 2012 08:51:21 MST</pubDate>
<description>ROCHESTER, N.Y., Feb.&amp;#160;10, 2012 /-&amp;#160;VirtualScopics, Inc. (NASDAQ:   VSCP ), a leading provider of quantitative imaging for clinical trials, announced today that Mr. Jeff Markin, the company's president and chief executive officer, will be presenting a corporate overview at the upcoming 14th Annual BIO CEO &amp;amp; Investor Conference at the Waldorf Astoria in New York City. Mr....&lt;img src="http://feeds.feedburner.com/~r/latest-medical-technology/~4/blS1bGyMVNU" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.bio-medicine.org/medicine-technology-1/VirtualScopics-to-Present-at-the-14th-Annual-BIO-CEO--26amp-3B-Investor-Conference-23982-1/</feedburner:origLink></item>
<item>
<title><![CDATA[Large Orthopedic Practice Receives Viztek's Complete Orthopedic DR+PACS Bundle]]></title>
<link>http://feeds.bio-medicine.org/~r/latest-medical-technology/~3/bjx8Ax8KmQk/</link>
<pubDate>Fri, 10 Feb 2012 08:50:22 MST</pubDate>
<description>RALEIGH, N.C., Feb. 10, 2012 /-&amp;#160;Viztek, the digital radiology solution provider, has installed its Opal-ORTHO PACS and ViZion DR U-Arm at Edison Metuchen Orthopaedic Group (EMOG) in Edison, NJ. The orthopaedic facility has&amp;#160;eleven orthopaedic surgeons and a psychiatrist with&amp;#160;onsite x-ray and access to an MRI facility and&amp;#160;an ambulatory surgery center in the same bu...&lt;img src="http://feeds.feedburner.com/~r/latest-medical-technology/~4/bjx8Ax8KmQk" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.bio-medicine.org/medicine-technology-1/Large-Orthopedic-Practice-Receives-Vizteks-Complete-Orthopedic-DR+PACS-Bundle-23981-1/</feedburner:origLink></item>
<item>
<title><![CDATA[Zacks' Voice of the People highlights opportunities with Walgreen, Occidental Petroleum and Brown &amp; Brown]]></title>
<link>http://feeds.bio-medicine.org/~r/latest-medical-technology/~3/OEADWnOLfc8/</link>
<pubDate>Fri, 10 Feb 2012 07:51:19 MST</pubDate>
<description>CHICAGO, Feb. 10, 2012 /-&amp;#160;Zacks highlights commentary from People and Picks Trader  " MightyMo " .   (Logo:&amp;#160;  http://photos.prnewswire.com/prnh/20101027/ZIRLOGO )   For more Voice of the People, visit  http://at.zacks.com/?id=5851    Featured Post    Market Percolates, Doubters Wait    They're coming out. The doubters, the doomsayers, the media 'fools' and of course the tr...&lt;img src="http://feeds.feedburner.com/~r/latest-medical-technology/~4/OEADWnOLfc8" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.bio-medicine.org/medicine-technology-1/Zacks-Voice-of-the-People-highlights-opportunities-with-Walgreen--Occidental-Petroleum-and-Brown--26amp-3B-Brown-23980-1/</feedburner:origLink></item>
<item>
<title><![CDATA[Pharma IQ Publishes Big Pharma Global Recession Report - 44.4% Fear Redundancy in 2012]]></title>
<link>http://feeds.bio-medicine.org/~r/latest-medical-technology/~3/dpdoZeZSeGQ/</link>
<pubDate>Fri, 10 Feb 2012 05:51:00 MST</pubDate>
<description>LONDON, February 10, 2012 /-   Industry wide economic climate study reveals bleak outlook for Pharmaceutical Industry in new report from Pharma-IQ.com   In the wake of high profile staff cuts at multinational global pharmaceutical and biotech companies, leading industry network Pharma IQ conducted a large scale study into job stability and future prospects for the industry in 2012....&lt;img src="http://feeds.feedburner.com/~r/latest-medical-technology/~4/dpdoZeZSeGQ" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.bio-medicine.org/medicine-technology-1/Pharma-IQ-Publishes-Big-Pharma-Global-Recession-Report---44-4-25-Fear-Redundancy-in-2012-23979-1/</feedburner:origLink></item>
<item>
<title><![CDATA[Soligenix Announces Results From Its Phase 1/2 Clinical Trial of SGX201 for the Prevention of Acute Radiation Enteritis]]></title>
<link>http://feeds.bio-medicine.org/~r/latest-medical-technology/~3/zGGob0KTKHM/</link>
<pubDate>Fri, 10 Feb 2012 05:08:48 MST</pubDate>
<description>PRINCETON, N.J., Feb. 10, 2012 /- Soligenix, Inc. (OTCBB: SNGXD) (Soligenix or the Company), a development stage biopharmaceutical company, announced preliminary results today from a Phase 1/2 clinical trial evaluating SGX201, a time-release formulation of oral beclomethasone 17,21-dipropionate (oral BDP), for the prevention of acute radiation enteritis.    The Phase 1/2 protocol BD...&lt;img src="http://feeds.feedburner.com/~r/latest-medical-technology/~4/zGGob0KTKHM" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.bio-medicine.org/medicine-technology-1/Soligenix-Announces-Results-From-Its-Phase-1-2-Clinical-Trial-of-SGX201-for-the-Prevention-of-Acute-Radiation-Enteritis-23978-1/</feedburner:origLink></item>
<item>
<title><![CDATA[Sleep Breathing Machine Shows Clear Benefits in Children with Sleep Apnea]]></title>
<link>http://feeds.bio-medicine.org/~r/latest-medical-technology/~3/GbRlvfJHkY0/</link>
<pubDate>Fri, 10 Feb 2012 12:29:51 MST</pubDate>
<description>PHILADELPHIA, Feb. 10, 2012 /PRNewswire-USNewswire/ -- Children and adolescents with obstructive sleep apnea had substantial improvements in attention, anxiety and quality of life after treatment with positive airway pressure (PAP)&amp;#8212;a nighttime therapy in which a machine delivers a stream of air through a mask into the nose.    "The benefits occurred even when children didn't fully adhere t...&lt;img src="http://feeds.feedburner.com/~r/latest-medical-technology/~4/GbRlvfJHkY0" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.bio-medicine.org/medicine-technology-1/Sleep-Breathing-Machine-Shows-Clear-Benefits-in-Children-with-Sleep-Apnea-23977-1/</feedburner:origLink></item>
<item>
<title><![CDATA[Faruqi &amp; Faruqi, LLP Announces Investigation of BioSante Pharmaceuticals, Inc.]]></title>
<link>http://feeds.bio-medicine.org/~r/latest-medical-technology/~3/GuQG0rxrBro/</link>
<pubDate>Thu, 09 Feb 2012 07:39:56 MST</pubDate>
<description>NEW YORK, Feb. 9, 2012 /-&amp;#160;Faruqi &amp;amp; Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at BioSante Pharmaceuticals, Inc. ("BioSante" or the "Company") (Nasdaq: BPAX).&amp;#160; &amp;#160;   (Logo:  http://photos.prnewswire.com/prnh/20120119/MM38856LOGO  )   The investigation focuses on whether the Company and its executives violated fede...&lt;img src="http://feeds.feedburner.com/~r/latest-medical-technology/~4/GuQG0rxrBro" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.bio-medicine.org/medicine-technology-1/Faruqi--26amp-3B-Faruqi--LLP-Announces-Investigation-of-BioSante-Pharmaceuticals--Inc--23976-1/</feedburner:origLink></item>
<item>
<title><![CDATA[New Data Reveals That Total Knee Replacement Can be Deferred Using Biologic and Bionic Meniscus Replacement Procedures]]></title>
<link>http://feeds.bio-medicine.org/~r/latest-medical-technology/~3/-VOfeyRGlh0/</link>
<pubDate>Thu, 09 Feb 2012 05:32:08 MST</pubDate>
<description>SAN FRANCISCO, Feb. 9, 2012 /- This week at American Academy of Orthopedic Surgeons in San Francisco, a group of renowned orthopedic surgeons from around the world gathered to discuss the latest findings for meniscus transplantations. &amp;#160;New data on knee joint cartilage and meniscus transplantation presented at the 27th annual Meniscus Transplantation Study Group revealed that th...&lt;img src="http://feeds.feedburner.com/~r/latest-medical-technology/~4/-VOfeyRGlh0" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.bio-medicine.org/medicine-technology-1/New-Data-Reveals-That-Total-Knee-Replacement-Can-be-Deferred-Using-Biologic-and-Bionic-Meniscus-Replacement-Procedures-23975-1/</feedburner:origLink></item>
<item>
<title><![CDATA[Unilife Corporation Announces Financial Results for Fiscal Year 2012 Second Quarter]]></title>
<link>http://feeds.bio-medicine.org/~r/latest-medical-technology/~3/-51eV-oT6oA/</link>
<pubDate>Thu, 09 Feb 2012 05:30:40 MST</pubDate>
<description>YORK, Pa., Feb. 9, 2012 /-   Unilife Corporation ("Unilife" or "Company") (NASDAQ:   UNIS ; ASX: UNS) today announced financial results for the quarter ended December 31, 2011 (Second Quarter of Fiscal Year 2012).    Recent Highlights:    Signed a clinical development agreement for a novel device for targeted organ delivery in November 2011; Unilife will receive $1.4 million in init...&lt;img src="http://feeds.feedburner.com/~r/latest-medical-technology/~4/-51eV-oT6oA" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.bio-medicine.org/medicine-technology-1/Unilife-Corporation-Announces-Financial-Results-for-Fiscal-Year-2012-Second-Quarter-23974-1/</feedburner:origLink></item>
<item>
<title><![CDATA[Medicomp Systems Hosts Quipstar, World's Favorite HIT Quiz Show, at HIMSS12]]></title>
<link>http://feeds.bio-medicine.org/~r/latest-medical-technology/~3/An07ghgIVX4/</link>
<pubDate>Thu, 09 Feb 2012 05:28:31 MST</pubDate>
<description>CHANTILLY, Va., Feb. 9, 2012 /- Medicomp Systems will premiere Quipstar,  World's Favorite HIT   Quiz Show , on Tuesday, February 21 at HIMSS12. The interactive health information technology quiz show will run February 21 through 23 at Medicomp's exhibit, booth 855. Contestants will compete for prizes using Quippe&amp;#174;, Medicomp's integrated physician and nursing documentation tool...&lt;img src="http://feeds.feedburner.com/~r/latest-medical-technology/~4/An07ghgIVX4" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.bio-medicine.org/medicine-technology-1/Medicomp-Systems-Hosts-Quipstar--Worlds-Favorite-HIT-Quiz-Show--at-HIMSS12-23973-1/</feedburner:origLink></item>
<item>
<title><![CDATA[Winner Medical Reports First Quarter of Fiscal 2012 Results]]></title>
<link>http://feeds.bio-medicine.org/~r/latest-medical-technology/~3/SpD53rkB89E/</link>
<pubDate>Thu, 09 Feb 2012 05:28:04 MST</pubDate>
<description>SHENZHEN, China, Feb. 9, 2012 /PRNewswire-Asia/&amp;#160;-- Winner Medical Group Inc. (Nasdaq:   WWIN ) ("Winner Medical" or the "Company"), a leading China-based exporter and retailer of high-quality medical dressings and consumer products made from 100% cotton, today reported consolidated financial results for the first quarter of fiscal 2012, which ended December 31, 2011.    First Quarter of Fis...&lt;img src="http://feeds.feedburner.com/~r/latest-medical-technology/~4/SpD53rkB89E" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.bio-medicine.org/medicine-technology-1/Winner-Medical-Reports-First-Quarter-of-Fiscal-2012-Results-23972-1/</feedburner:origLink></item>
<item>
<title><![CDATA[POLARCUP™ Dual Mobility Hip System From Smith &amp; Nephew Now Available in US]]></title>
<link>http://feeds.bio-medicine.org/~r/latest-medical-technology/~3/TRA92Lu7EO4/</link>
<pubDate>Thu, 09 Feb 2012 05:26:57 MST</pubDate>
<description>LONDON, Feb. 9, 2012 /- &amp;#160; Smith &amp;amp; Nephew (NYSE:   SNN ; LSE: SN), the global medical technology business, is introducing the clinically proven POLARCUP&amp;#8482; Dual Mobility Hip System to orthopaedic surgeons in the US at this year's American Academy of Orthopaedic Surgeons (AAOS) annual meeting in San Francisco. The system is specifically designed to address the challenges...&lt;img src="http://feeds.feedburner.com/~r/latest-medical-technology/~4/TRA92Lu7EO4" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.bio-medicine.org/medicine-technology-1/POLARCUP-u2122-Dual-Mobility-Hip-System-From-Smith--26amp-3B-Nephew-Now-Available-in-US-23971-1/</feedburner:origLink></item>
<item>
<title><![CDATA[InterMune Names Jonathan A. Leff, M.D., as Executive Vice President of Research and Development]]></title>
<link>http://feeds.bio-medicine.org/~r/latest-medical-technology/~3/AUXPa-M4pak/</link>
<pubDate>Thu, 09 Feb 2012 05:26:13 MST</pubDate>
<description>BRISBANE, Calif., Feb. 9, 2012 /-&amp;#160;InterMune, Inc. (NASDAQ:   ITMN ) today announced that Jonathan A. Leff, M.D., has been appointed InterMune's Executive Vice President of Research and Development, effective February 27, 2012.&amp;#160;&amp;#160; In the newly created position, Dr. Leff will be responsible for the leadership and oversight of all groups within the company's Research and...&lt;img src="http://feeds.feedburner.com/~r/latest-medical-technology/~4/AUXPa-M4pak" height="1" width="1"/&gt;</description>
<feedburner:origLink>http://www.bio-medicine.org/medicine-technology-1/InterMune-Names-Jonathan-A--Leff--M-D---as-Executive-Vice-President-of-Research-and-Development-23970-1/</feedburner:origLink></item>
</channel>
</rss>

